# RIFAMPIN

NDC: 24658-802
Generic name: rifampin
Labeler / Manufacturer: PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230314

FDA application: ANDA064150

## Active ingredients

- RIFAMPIN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24658-802"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24658-802
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28109dee-3e5e-492b-b7d9-9ba46c0b5324
